---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-060880"
form_type: "8-K"
ticker: "CYCU"
cik: "0001868419"
company_name: "Cycurion, Inc."
filed_at: "2026-09-08T19:15:48+00:00"
generated_at: "2026-09-08T19:17:05.503190+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Cycurion announces ~$800K annual contract spend from pharma AI, NACCHO, and other engagements

## Summary
- New engagements total approximately $800,000 in annual contract spend, first public announcement.
- Pharmaceutical organization engaged Cycurion to support an AI Center of Excellence.
- NACCHO awarded new work; Cycurion is a Diamond Affiliate Partner.
- Scope includes business continuity, cybersecurity assessments, program management, and AI operating capability.
- CEO L. Kevin Kelly: commercial healthcare and life-sciences are primary growth markets beyond government.

## SEC filing metadata
- accession: 0001628280-26-060880
- form_type: 8-K
- ticker: CYCU
- cik: 0001868419
- company_name: Cycurion, Inc.
- filed_at: 2026-09-08T19:15:48+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1868419/000162828026060880/0001628280-26-060880-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1868419/000162828026060880/cycu-20260903.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-060880
- JSON: https://secwatch.observer/filing/0001628280-26-060880.json
- Plain text: https://secwatch.observer/filing/0001628280-26-060880.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.